Cargando…
Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
Gender-affirming hormone treatment generally by cross-sex hormones is an important strategy for transgender people to achieve the physical features affirming their experienced gender. Estrogens and androgens are administrated, usually for a long time, to transgender women and transgender men who wou...
Autores principales: | Masumori, Naoya, Nakatsuka, Mikiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072899/ https://www.ncbi.nlm.nih.gov/pubmed/37025940 http://dx.doi.org/10.1253/circrep.CR-23-0021 |
Ejemplares similares
-
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
por: Sánchez-Toscano, Esteban, et al.
Publicado: (2023) -
Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men
por: Kirisawa, Takahiro, et al.
Publicado: (2021) -
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021) -
Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019) -
Comparison of the Uroflowmetry Parameter Results Between Transgender Males Undergoing Gender-Affirming Hormone Therapy and Age-Matched Cisgender Females: Preliminary Data
por: Matsuo, Kazuna, et al.
Publicado: (2019)